Importantly, these results aligned with our earlier observation that ROCK1 knockdown suppresses ESCC progression, this finding is also supported by previous studies,[25, 26] thereby further solidifying ROCK1 as a downstream effector of ARL5B in lipid metabolic reprogramming. This evidence concerns the gene ARL5B and esophageal squamous cell carcinoma.